vs
Side-by-side financial comparison of EDGEWELL PERSONAL CARE Co (EPC) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
EDGEWELL PERSONAL CARE Co is the larger business by last-quarter revenue ($422.8M vs $226.2M, roughly 1.9× USANA HEALTH SCIENCES INC). USANA HEALTH SCIENCES INC runs the higher net margin — 0.1% vs -15.5%, a 15.6% gap on every dollar of revenue. On growth, USANA HEALTH SCIENCES INC posted the faster year-over-year revenue change (-10.0% vs -11.6%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (3.1% CAGR vs -16.0%).
The Edgewell Personal Care Company is an American multinational consumer products company headquartered in Shelton, Connecticut. It was formed in 2015 following the corporate spin-off from Energizer Holdings, Inc..
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
EPC vs USNA — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $422.8M | $226.2M |
| Net Profit | $-65.7M | $180.0K |
| Gross Margin | 38.1% | 78.2% |
| Operating Margin | -4.5% | 1.7% |
| Net Margin | -15.5% | 0.1% |
| Revenue YoY | -11.6% | -10.0% |
| Net Profit YoY | -3028.6% | -74.0% |
| EPS (diluted) | $-1.41 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $422.8M | $226.2M | ||
| Q3 25 | $600.5M | $213.7M | ||
| Q2 25 | $627.2M | $235.8M | ||
| Q1 25 | $580.7M | $249.5M | ||
| Q4 24 | $415.1M | $213.6M | ||
| Q3 24 | $517.6M | $200.2M | ||
| Q2 24 | $647.8M | $212.9M | ||
| Q1 24 | $599.4M | — |
| Q4 25 | $-65.7M | $180.0K | ||
| Q3 25 | $-30.6M | $-6.5M | ||
| Q2 25 | $29.1M | $9.7M | ||
| Q1 25 | $29.0M | $9.4M | ||
| Q4 24 | $-2.1M | $4.5M | ||
| Q3 24 | $8.8M | $10.6M | ||
| Q2 24 | $49.0M | $10.4M | ||
| Q1 24 | $36.0M | — |
| Q4 25 | 38.1% | 78.2% | ||
| Q3 25 | 37.9% | 77.2% | ||
| Q2 25 | 42.8% | 78.7% | ||
| Q1 25 | 44.1% | 79.0% | ||
| Q4 24 | 41.6% | 82.0% | ||
| Q3 24 | 41.1% | 80.4% | ||
| Q2 24 | 44.3% | 81.1% | ||
| Q1 24 | 43.1% | — |
| Q4 25 | -4.5% | 1.7% | ||
| Q3 25 | -4.2% | 0.6% | ||
| Q2 25 | 8.6% | 7.1% | ||
| Q1 25 | 10.1% | 6.3% | ||
| Q4 24 | 2.2% | 3.8% | ||
| Q3 24 | 3.9% | 7.8% | ||
| Q2 24 | 12.8% | 8.4% | ||
| Q1 24 | 11.7% | — |
| Q4 25 | -15.5% | 0.1% | ||
| Q3 25 | -5.1% | -3.1% | ||
| Q2 25 | 4.6% | 4.1% | ||
| Q1 25 | 5.0% | 3.8% | ||
| Q4 24 | -0.5% | 2.1% | ||
| Q3 24 | 1.7% | 5.3% | ||
| Q2 24 | 7.6% | 4.9% | ||
| Q1 24 | 6.0% | — |
| Q4 25 | $-1.41 | $-0.10 | ||
| Q3 25 | $-0.65 | $-0.36 | ||
| Q2 25 | $0.62 | $0.52 | ||
| Q1 25 | $0.60 | $0.49 | ||
| Q4 24 | $-0.04 | $0.23 | ||
| Q3 24 | $0.18 | $0.56 | ||
| Q2 24 | $0.98 | $0.54 | ||
| Q1 24 | $0.72 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $158.4M |
| Total DebtLower is stronger | $1.5B | — |
| Stockholders' EquityBook value | $1.5B | — |
| Total Assets | $3.8B | $742.9M |
| Debt / EquityLower = less leverage | 1.03× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $158.4M | ||
| Q3 25 | — | $145.3M | ||
| Q2 25 | — | $151.3M | ||
| Q1 25 | — | $179.6M | ||
| Q4 24 | — | $181.8M | ||
| Q3 24 | $209.1M | $364.9M | ||
| Q2 24 | — | $332.4M | ||
| Q1 24 | — | — |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.6B | $528.1M | ||
| Q2 25 | $1.6B | $531.1M | ||
| Q1 25 | $1.5B | $529.8M | ||
| Q4 24 | $1.5B | $532.1M | ||
| Q3 24 | $1.6B | $533.1M | ||
| Q2 24 | $1.6B | $512.2M | ||
| Q1 24 | $1.6B | — |
| Q4 25 | $3.8B | $742.9M | ||
| Q3 25 | $3.8B | $726.6M | ||
| Q2 25 | $3.8B | $734.5M | ||
| Q1 25 | $3.8B | $746.6M | ||
| Q4 24 | $3.7B | $748.2M | ||
| Q3 24 | $3.7B | $671.3M | ||
| Q2 24 | $3.7B | $631.4M | ||
| Q1 24 | $3.8B | — |
| Q4 25 | 1.03× | — | ||
| Q3 25 | 0.89× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 0.81× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.88× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-125.9M | — |
| Free Cash FlowOCF − Capex | $-137.5M | — |
| FCF MarginFCF / Revenue | -32.5% | — |
| Capex IntensityCapex / Revenue | 2.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $36.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-125.9M | — | ||
| Q3 25 | $74.1M | $-2.0M | ||
| Q2 25 | $114.8M | $12.2M | ||
| Q1 25 | $45.1M | $15.5M | ||
| Q4 24 | $-115.6M | $5.8M | ||
| Q3 24 | $-388.3M | $29.5M | ||
| Q2 24 | $101.2M | $8.0M | ||
| Q1 24 | $129.0M | — |
| Q4 25 | $-137.5M | — | ||
| Q3 25 | $46.5M | $-5.2M | ||
| Q2 25 | $99.3M | $7.2M | ||
| Q1 25 | $28.0M | $12.7M | ||
| Q4 24 | $-132.4M | $4.0M | ||
| Q3 24 | $-414.2M | $27.1M | ||
| Q2 24 | $88.6M | $5.3M | ||
| Q1 24 | $117.5M | — |
| Q4 25 | -32.5% | — | ||
| Q3 25 | 7.7% | -2.4% | ||
| Q2 25 | 15.8% | 3.0% | ||
| Q1 25 | 4.8% | 5.1% | ||
| Q4 24 | -31.9% | 1.9% | ||
| Q3 24 | -80.0% | 13.6% | ||
| Q2 24 | 13.7% | 2.5% | ||
| Q1 24 | 19.6% | — |
| Q4 25 | 2.7% | — | ||
| Q3 25 | 4.6% | 1.5% | ||
| Q2 25 | 2.5% | 2.1% | ||
| Q1 25 | 2.9% | 1.1% | ||
| Q4 24 | 4.0% | 0.8% | ||
| Q3 24 | 5.0% | 1.2% | ||
| Q2 24 | 1.9% | 1.3% | ||
| Q1 24 | 1.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.95× | 1.27× | ||
| Q1 25 | 1.56× | 1.65× | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | -44.13× | 2.78× | ||
| Q2 24 | 2.07× | 0.77× | ||
| Q1 24 | 3.58× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPC
| Other | $242.0M | 57% |
| Sunand Skin Care Segment | $131.5M | 31% |
| Shavinggelsandcreams | $32.3M | 8% |
| Wipes And Other Skin Care Products | $17.0M | 4% |
USNA
Segment breakdown not available.
